Diagnamed Holdings Corp. (CSE: DMED)
Canada
· Delayed Price · Currency is CAD
0.0300
+0.0100 (50.00%)
Dec 3, 2024, 12:18 PM EST
Diagnamed Holdings Statistics
Total Valuation
Diagnamed Holdings has a market cap or net worth of CAD 2.40 million. The enterprise value is 2.23 million.
Market Cap | 2.40M |
Enterprise Value | 2.23M |
Important Dates
The next estimated earnings date is Friday, January 31, 2025.
Earnings Date | Jan 31, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Diagnamed Holdings has 80.05 million shares outstanding. The number of shares has increased by 0.01% in one year.
Current Share Class | n/a |
Shares Outstanding | 80.05M |
Shares Change (YoY) | +0.01% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 12.56% |
Owned by Institutions (%) | n/a |
Float | 62.16M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -3.65 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.74
Current Ratio | 0.74 |
Quick Ratio | 0.74 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -292.41% and return on invested capital (ROIC) is -234.74%.
Return on Equity (ROE) | -292.41% |
Return on Assets (ROA) | -92.22% |
Return on Capital (ROIC) | -234.74% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | 0.02 |
200-Day Moving Average | 0.03 |
Relative Strength Index (RSI) | 57.22 |
Average Volume (20 Days) | 140,714 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -783,530 |
Pretax Income | -610,020 |
Net Income | -610,020 |
EBITDA | n/a |
EBIT | -783,530 |
Earnings Per Share (EPS) | -0.01 |
Balance Sheet
Cash & Cash Equivalents | 172,502 |
Total Debt | n/a |
Net Cash | 172,502 |
Net Cash Per Share | 0.00 |
Equity (Book Value) | -71,488 |
Book Value Per Share | -0.00 |
Working Capital | -71,488 |
Cash Flow
Operating Cash Flow | -650,638 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Diagnamed Holdings does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.01% |
Shareholder Yield | -0.01% |
Earnings Yield | -25.40% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |